The BAHNO National Head and Neck Cancer Surveillance Audit
The National Head and Neck Cancer Surveillance Audit 2018 is a project conceived by the British Association of Head and Neck Oncologists and delivered by Integrate. Our aim is to recruit site leads from around 100 hospital sites throughout the UK. The position of ENT site lead and MaxFax site lead will be available for one ENT trainee and one MaxFax trainee per site. To apply to be a collaborator, click here to create an account and register your interest.
Rationale for the audit
Head and neck cancer is the sixth most common malignancy worldwide. In the UK, it is managed by a multidisciplinary team of surgical oncologists, oncologists, radiologists, pathologists and allied health professional. Post treatment surveillance is accepted as an essential element of patient care(ref). Follow-up serves a number of functions including: assessing treatment response, identification of recurrent or new primary tumours, managing complications, facilitating ongoing rehabilitation and addressing patients’ and their families’ social and psychological needs. Despite an acknowledge limited evidence base, The Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines published in 2016 set out surveillance recommendations. This audit seeks to assess national compliance with this guidance and, if required, explore ways in which this multifaceted surveillance model might be delivered more reliably in the context of stringent economic forces and an evolving evidence base.
Objectives and details
The 1st cycle of the BAHNO National Head and NECK Cancer Surveillance Audit is a combined 30-day retrospective and 30-day prospective audit of practice. Thereafter findings will be presented to the BAHNO council with a view to developing appropriate interventions prior to any subsequent audit cycle. The audit will include all patients undergoing scheduled appointments for the surveillance of treated head and neck cancer. This will include multidisciplinary, subspecialist and general clinics in both Otorhinolaryngology and maxillofacial surgery.
Data will be collected from across the UK, a 100-site target has been set for this project. The retrospective period will involve the review of clinical notes, the prospective period will involve the completion of locally approved audit proformas, in-lieu of medical continuation sheets, for inclusion in the hospital notes. Data extracted will then be entered into audit response form common to both audit periods and returned to the audit team as detailed below. This dual audit methodology will seek to quantify the limitations of clinical notes containing insufficient details for audit purposes versus the potential impact of audit proformas on patient care.